.On the heels of an FDA denial for its main rival Novo Nordisk, Eli Lilly is pulling ahead in the ra...
.Merely a handful of months after application the initial client in a phase 2 test for newly diagnos...
.Eli Lilly's search for excessive weight targets has actually led it to the dark genome. The Big Pha...
.Toolbox Biosciences is actually proceeding up. The cell therapy provider has added $325 thousand in...
.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has actually...
.Aelis Farma's chances of securing a quick, positive decision on a $one hundred million choice remit...
.ProKidney has ceased some of a pair of stage 3 trials for its own cell treatment for kidney illness...
.Vaxcyte revealed what experts named "impressive" phase 1/2 records for its own 31-valent pneumococc...
.Recursion has actually stumbled via an early examination of its own tech-enabled approach to medici...
.Contact it a situation of excellent chemical make up: Acepodia, a biotech based upon Nobel Champion...